Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing…
NEW YORK, July 15, 2024 /PRNewswire/ -- The global trenbolone enanthate market size is estimated to grow by USD 13.4 million from 2024-2028,…
WESTFORD, Mass., July 15, 2024 /PRNewswire/ -- According to SkyQuest, the global Active Pharmaceutical Ingredients (API) Market size was valued at…
The rise in minimally invasive surgeries is a key driver for the global electrosurgical devices market growth, as these procedures require…
WESTFORD, Mass., July 12, 2024 /PRNewswire/ -- According to SkyQuest, the global 3D Cell Culture Market size was valued at USD…
DIEPENBEEK, Belgium and ANAHEIM, Calif. , July 12, 2024 /PRNewswire/ -- Bedal International, a Belgian based medical device company delivering next…
Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company…
LOUISVILLE, Ky., July 12, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a…
SAN DIEGO and SUZHOU, China, July 12, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the…
Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST…